Effects of lifestyle and glucagon-like Peptide-1 receptor agonist-based therapies on waist circumference: A systematic review and meta-analysis
{{output}}
Background and aims: Central obesity, commonly assessed using waist circumference (WC), is strongly associated with cardiometabolic risk. While lifestyle interventions and glucagon-like peptide-1 receptor agonist-based therapies ... ...
